Northwestern Mutual Wealth Management
TEVA icon

Northwestern Mutual Wealth Management’s Teva Pharmaceuticals TEVA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$376K Buy
11,091
+149
+1% +$4.96K ﹤0.01% 1750
2026
Q1 		$330K Sell
10,942
-680
-6% -$21.9K ﹤0.01% 1713
2025
Q4 		$363K Buy
11,622
+276
+2% +$6.8K ﹤0.01% 1655
2025
Q3 		$229K Sell
11,346
-2,303
-17% -$40.4K ﹤0.01% 1745
2025
Q2 		$229K Sell
13,649
-1,148
-8% -$18.5K ﹤0.01% 1682
2025
Q1 		$227K Buy
14,797
+444
+3% +$7.93K ﹤0.01% 1618
2024
Q4 		$316K Sell
14,353
-1,089
-7% -$19.8K ﹤0.01% 1477
2024
Q3 		$278K Buy
15,442
+54
+0.4% +$945 ﹤0.01% 1517
2024
Q2 		$250K Buy
15,388
+148
+1% +$2.28K ﹤0.01% 1492
2024
Q1 		$215K Sell
15,240
-206
-1% -$2.6K ﹤0.01% 1531
2023
Q4 		$161K Sell
15,446
-9,139
-37% -$85.3K ﹤0.01% 1590
2023
Q3 		$251K Buy
24,585
+10,278
+72% +$95.7K ﹤0.01% 1385
2023
Q2 		$108K Sell
14,307
-124
-0.9% -$1K ﹤0.01% 1687
2023
Q1 		$128K Sell
14,431
-3,850
-21% -$38.1K ﹤0.01% 1599
2022
Q4 		$167K Sell
18,281
-135
-0.7% -$1.18K ﹤0.01% 1471
2022
Q3 		$149K Sell
18,416
-10,863
-37% -$96.1K ﹤0.01% 1494
2022
Q2 		$220K Sell
29,279
-61,528
-68% -$536K ﹤0.01% 1359
2022
Q1 		$853K Sell
90,807
-3,238
-3% -$27K ﹤0.01% 900
2021
Q4 		$754K Buy
94,045
+36,116
+62% +$326K ﹤0.01% 921
2021
Q3 		$565K Buy
57,929
+2,557
+5% +$23.9K ﹤0.01% 940
2021
Q2 		$549K Buy
55,372
+18,882
+52% +$200K ﹤0.01% 949
2021
Q1 		$421K Sell
36,490
-63
-0.2% -$722 ﹤0.01% 983
2020
Q4 		$353K Sell
36,553
-23
-0.1% -$220 ﹤0.01% 948
2020
Q3 		$330K Sell
36,576
-19,531
-35% -$207K ﹤0.01% 866
2020
Q2 		$692K Sell
56,107
-4,396
-7% -$49.7K ﹤0.01% 622
2020
Q1 		$543K Buy
60,503
+35,088
+138% +$359K ﹤0.01% 619
2019
Q4 		$249K Buy
25,415
+1,028
+4% +$9.18K ﹤0.01% 871
2019
Q3 		$168K Buy
24,387
+4,607
+23% +$35.3K ﹤0.01% 956
2019
Q2 		$183K Sell
19,780
-81
-0.4% -$977 ﹤0.01% 917
2019
Q1 		$311K Buy
19,861
+767
+4% +$13.5K ﹤0.01% 735
2018
Q4 		$295K Sell
19,094
-1,299
-6% -$26.6K ﹤0.01% 693
2018
Q3 		$439K Sell
20,393
-7,377
-27% -$171K ﹤0.01% 597
2018
Q2 		$675K Buy
27,770
+1,054
+4% +$21.5K ﹤0.01% 480
2018
Q1 		$457K Sell
26,716
-2,073
-7% -$40.5K ﹤0.01% 540
2017
Q4 		$546K Buy
28,789
+5,163
+22% +$77.7K ﹤0.01% 498
2017
Q3 		$416K Buy
23,626
+669
+3% +$15.1K ﹤0.01% 522
2017
Q2 		$762K Buy
22,957
+1,279
+6% +$39.6K 0.01% 398
2017
Q1 		$695K Buy
21,678
+2,322
+12% +$79.2K 0.01% 392
2016
Q4 		$702K Sell
19,356
-3,558
-16% -$142K 0.01% 384
2016
Q3 		$1.05M Buy
22,914
+974
+4% +$50.8K 0.01% 306
2016
Q2 		$1.1M Buy
21,940
+3,270
+18% +$174K 0.02% 293
2016
Q1 		$999K Buy
18,670
+2,452
+15% +$144K 0.02% 284
2015
Q4 		$1.06M Sell
16,218
-455
-3% -$28.1K 0.02% 256
2015
Q3 		$941K Buy
16,673
+1,816
+12% +$118K 0.02% 268
2015
Q2 		$878K Buy
14,857
+214
+1% +$13.2K 0.02% 268
2015
Q1 		$912K Buy
14,643
+197
+1% +$11.5K 0.03% 250
2014
Q4 		$831K Sell
14,446
-344
-2% -$19.2K 0.03% 250
2014
Q3 		$795K Buy
14,790
+2,359
+19% +$125K 0.03% 246
2014
Q2 		$652K Sell
12,431
-882
-7% -$45.1K 0.03% 247
2014
Q1 		$704K Sell
13,313
-2,117
-14% -$97.8K 0.03% 243
2013
Q4 		$619K Buy
15,430
+4,052
+36% +$160K 0.03% 248
2013
Q3 		$430K Buy
11,378
+530
+5% +$20.7K 0.02% 267
2013
Q2 		$425K Buy
+10,848
New +$422K 0.03% 269

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Northwestern Mutual Wealth Management's TEVA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management increased its Teva Pharmaceuticals (TEVA) stake by 1.4% in Q2 2026, buying an estimated $4.96K and bringing the position to 11,091 shares worth $376K. The position accounts for ﹤0.01% of the portfolio, ranked #1750.

Northwestern Mutual Wealth Management first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.1M in Q2 2016. 673 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Northwestern Mutual Wealth Management held 11,091 shares of Teva Pharmaceuticals worth $376K as of Q2 2026.
  • Northwestern Mutual Wealth Management bought 149 Teva Pharmaceuticals shares in Q2 2026, an estimated $4.96K.
  • Teva Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #1750 holding.
  • Northwestern Mutual Wealth Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Northwestern Mutual Wealth Management's Teva Pharmaceuticals position peaked at $1.1M in Q2 2016.
  • 673 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.